Skip to main content

Descubrimiento de un gen asociado a trastorno de la atención e hiperactividad. Implicancias terapéuticas

Se descubre una asociación entre el TDAH y el gen Latrophilina 3 (LPHN3), lo que abre una vía para el desarrollo de tratamientos farmacológicos más eficaces.



MOL PSYCHIATRY. 2010 FEB [noticias] [17/2/2010] Investigadores de los Institutos Nacionales de la Salud en Bethesda (Estados Unidos) han descubierto un vínculo entre el trastorno por déficit de atención con hiperactividad (TDAH) y el gen Latrophilina 3 (LPHN3).

Según los investigadores, la misma variante del gen LPHN3 está también asociada con la respuesta a la medicación estimulante, lo que podría ayudar a identificar a aquellas personas que responderían de forma positiva a esta terapia y al futuro desarrollo de tratamienGuardar como borradortos farmacológicos más eficaces para el TDAH.

Los científicos, dirigidos por Maximilian Muenke y Mauricio Arcos-Burgos, realizaron un estudio de vinculación amplia de genoma de 18 familias afectadas por el TDAH en una población aislada de Colombia con el objetivo de estudiar las causas genéticas del trastorno.

Los resultados mostraron una asociación entre el TDAH y una región genómica en LPHN3. Los investigadores replicaron entonces estos resultados en muestras de cinco poblaciones de otras áreas del mundo, incluyendo Alemania, Noruega, España y otras dos de Estados Unidos.

Los estudios de imágenes cerebrales confirmaron más tarde esta conexión, mostrando que las variantes de LPHN3 se expresaban en regiones cerebrales asociadas a la atención y la actividad y que están asociadas con la respuesta a la medicación estimulante.

El vínculo entre TDAH y LPHN3 sugiere nuevos mecanismos moleculares asociados a TDAH, que podrían ayudar al desarrollo de tratamientos farmacológicos que se dirijan a nuevos genes y mecanismos neurales.

La conexión entre LPHN3 y la respuesta a la medicación estimulante podría ayudar a identificar a aquellas personas susceptibles al TDAH y a aquellos más propensos a responder de forma positiva a la medicación estimulante como tratamiento.

Para acceder al texto completo consulte las características de suscripción de la fuente original: www.nature.com/mp/

Comments

Popular posts from this blog

Nordic Walking Benefits, ADHD and Diet, Supplements and Cancer, Sources of Fiber

A Better Way To Walk: Nordic Walking Improves Quality of Life, Depression, and Functional Capacity SciTechDaily Reference: “Sustained Effects of Different Exercise Modalities on Physical and Mental Health in Patients With Coronary Artery Disease: A Randomized ... Dietary Interventions for ADHD: Emerging Research and Considerations There has been increasing interest in the role that diet and supplements play in the treatment of attention-deficit/hyperactivity disorder (ADHD) symptoms, from patients and researchers alike. Diet is an important treatment approach to consider, as it is a lifestyle change rather than a medication. Additionally, at least 10% to 30% of children with ADHD are non-responsive to, or experience adverse effects from, ADHD medications­­­­.1 A dietary approach to ADHD can be complementary to a conventional pharmacological approach, giving patients and their families more options toward a personalized treatment plan. This article will examine current research about di

More People Are Microdosing for Mental Health. But Does It Work?

By Dana G Smith. Joseph started microdosing psychedelics five years ago to try to improve his mental health. “I was just kind of in this depression, in this rut,” he said. “I was unhappy and angry and agitated all the time, and it went against the way that I saw myself.” Depression and anxiety run in Joseph’s family, and he’d been prescribed Prozac as a kid. But when symptoms of depression returned in his early 30s, he didn’t want to go back to a prescription drug. Joseph, an Austin-based designer (he asked to withhold his full name, citing privacy concerns surrounding mental health issues and illegal drug use), came across research from Johns Hopkins University about psilocybin, the active ingredient in hallucinogenic, or “magic,” mushrooms. In a small study, full doses of the drug helped cancer patients cope with depression and anxiety. Then he read anecdotes of Silicon Valley influencers claiming increased energy from taking tiny doses of psychedelics. So he decided to start microdo

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable